Recombinant Human Early Placenta Insulin-Like Peptide/INSL4/Placentin Protein(C-6His)
Cat#:TP05953应用:Positive Control; Immunogen; SDS-PAGE; WB
| Product Name: | Anti- Human SL4 Polyclonal Antibody |
| Cat No.: | PA04615 |
| Clonality: | Polyclonal |
| Species Reactivity: | Human |
| Tested Applications: | WB,IHC-p,IF,ELISA |
| Recommended Dilution: | WB 1:500-1:2000, IHC 1:100-1:300, IF 1:200-1:1000, ELISA 1:20000 |
| Size: | 30ul 50ul 100uL |
| Format: | Liquid |
| Source: | Rabbit |
| Purification Method: | Antigen Affinity Purification |
| Isotype: | IgG |
| Conjugate: | Unconjugated |
| Storage: | -20℃ |
| Immunogen: | Synthesized peptide derived from the Internal region of human INSL4 |
| GenBank Accession Number: | Q14641 |
| Gene ID (NCBI): | 3641 |
| Synonyms: | Early Placenta Insulin-Like Peptide; EPIL; Insulin-Like Peptide 4; Placentin; INSL4 |
| Background: | Expressed in placenta, uterus and in fetal perichondrium. Expression levels were increased in both early placentas and molar pregnancies and were reduced in choriocarcinoma cells. |
| Category: | Primary Ab |